Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar

World Journal of Gastroenterology

Volumn 21, Issue 2, 2015, Pages 612-619

  Myint, Thein ^a   Shiota, Seiji ^b   Vilaichone, Ratha Korn ^c   Ni, New ^d   Aye, Than Than ^e   Matsuda, Miyuki ^b   Tran, Trang Thi Huyen ^f   Uchida, Tomohisa ^b   Mahachai, Varocha ^a   Yamaoka, Yoshio ^b  

^a Yangon General Hospital   (Myanmar)

^b OITA UNIVERSITY   (Japan)

^c THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^d University of Medicine (Mandalay)   (Myanmar)

^e Thingangyun Sanpya General Hospital (TSGH)   (Myanmar)

^f Bangkok Medical Center   (Thailand)

Author keywords

Atrophy; Helicobacter pylori; Myanmar; Pepsinogen

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

ADOLESCENT; ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM CULTURE; CLINICAL EVALUATION; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; GROUPS BY AGE; HEALTH SURVEY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MYANMAR; OPERATIVE LINK FOR GASTRITIS ASSESSMENT SYSTEM; PEPTIC ULCER; PREVALENCE; RAPID UREASE TEST; SEROLOGY; STOMACH ATROPHY; STOMACH CANCER; STOMACH MUCOSA; SYDNEY SYSTEM; AGE; AGE DISTRIBUTION; ATROPHY; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; STOMACH ULCER; VERY ELDERLY; YOUNG ADULT; CONTROLLED STUDY; GASTROSCOPY; HISTOLOGY; HUMAN TISSUE; INCIDENCE; SCORING SYSTEM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ATROPHY; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MYANMAR; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STOMACH ULCER; YOUNG ADULT;

EID: 84964696144     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i2.612     Document Type: Article

References (39)

1. Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 168-174 [PMID: 23358394 DOI: 10.1038/nrgastro.2013.9]
2. Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer 2009; 12: 79-87 [PMID: 19562461 DOI: 10.1007/s10120-009-0507-x]
3. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21: 205-214 [PMID: 17382273]
4. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010; 7: 629-641 [PMID: 20938460 DOI: 10.1038/nrgastro.2010.154]
5. Mukhopadhyay AK, Kersulyte D, Jeong JY, Datta S, Ito Y, Chowdhury A, Chowdhury S, Santra A, Bhattacharya SK, Azuma T, Nair GB, Berg DE. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 2000; 182: 3219-3227 [PMID: 10809703]
6. Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, Graham DY. Helicobacter pylori in North and South America before Columbus. FEBS Lett 2002; 517: 180-184 [PMID: 12062433 DOI: 10.1016/S0014-5793(02)02617-0]
7. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 2004; 9: 453-459 [PMID: 15361085 DOI: 10.1111/j.1083-4389.2004.00260.x]
8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
9. Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol 2012; 12: 203-213 [PMID: 22197766 DOI: 10.1016/j.meegid.2011.12.002]
10. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007; 42: 2-10 [PMID: 17190755 DOI: 10.1080/00365520600863720]
11. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006; 9: 245-253 [PMID: 17235625 DOI: 10.1007/s10120-006-0397-0]
12. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181 [PMID: 8827022]
13. Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-ABC method. Proc Jpn Acad Ser B Phys Biol Sci 2011; 87: 405-414 [PMID: 21785258]
14. Uchida T, Kanada R, Tsukamoto Y, Hijiya N, Matsuura K, Yano S, Yokoyama S, Kishida T, Kodama M, Murakami K, Fujioka T, Moriyama M. Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci 2007; 98: 521-528 [PMID: 17284255 DOI: 10.1111/j.1349-7006.2007.00415.x]
15. Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol 2012; 12: 10 [PMID: 22289789 DOI: 10.1186/1471-230X-12-10]
16. Rugge M, Genta RM. Staging gastritis: an international proposal. Gastroenterology 2005; 129: 1807-1808 [PMID: 16285989 DOI: 10.1053/j.gastro.2005.09.056]
17. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-636 [PMID: 17142647 DOI: 10.1136/gut.2006.106666]
18. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011; 16 Suppl 1: 1-9 [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874.x]
19. Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol 2013; 7: 35-40 [PMID: 23265147 DOI: 10.1586/ egh.12.67]
20. Lee YY, Mahendra Raj S, Graham DY. Helicobacter pylori infection-A boon or a bane: lessons from studies in a lowprevalence population. Helicobacter 2013; 18: 338-346 [PMID: 23607896 DOI: 10.1111/hel.12058]
21. Shiota S, Mahachai V, Vilaichone RK, Ratanachu-ek T, Tshering L, Uchida T, Matsunari O, Yamaoka Y. Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol 2013; 62: 1571-1578 [PMID: 23831768 DOI: 10.1099/jmm.0.060905-0]
22. Satoh K, Osawa H, Yoshizawa M, Nakano H, Hirasawa T, Kihira K, Sugano K. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008; 13: 225-229 [PMID: 18466398 DOI: 10.1111/j.1523-5378.2008.00599.x]
23. Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, Shiota S, Nakagawa Y, Mizukami K, Fujioka T. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol 2012; 47: 394-403 [PMID: 22138891 DOI: 10.1007/ s00535-011-0504-9]
24. Ang TL, Fock KM, Dhamodaran S, Teo EK, Tan J. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J Gastroenterol Hepatol 2005; 20: 1603-1609 [PMID: 16174081 DOI: 10.1111/j.1440-1746.2005.03898.x]
25. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-365 [PMID: 18318820]
26. Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver 2010; 4: 307-319 [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307]
27. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-287 [PMID: 18308253 DOI: 10.1016/S1470-2045(08)70072-X]
28. Brenner H, Rothenbacher D, Weck MN. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 2007; 121: 2782-2786 [PMID: 17691112 DOI: 10.1002/ ijc.22992]
29. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007; 8: 15-22 [PMID: 17261130 DOI: 10.1111/ j.1443-9573.2007.00271.x]
30. Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis 2013; 14: 341-349 [PMID: 23452293 DOI: 10.1111/1751-2980.12054]
31. Chattopadhyay S, Datta S, Chowdhury A, Chowdhury S, Mukhopadhyay AK, Rajendran K, Bhattacharya SK, Berg DE, Nair GB. Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-Associated disease and healthy volunteers. J Clin Microbiol 2002; 40: 2622-2625 [PMID: 12089290]
32. Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, Nagano O, Matsuzaki J, Hibi T. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 2012; 12: 764-777 [PMID: 23245321 DOI: 10.1016/j.chom.2012.10.014]
33. Malfertheiner P, Megraud F, OMorain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection-The Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/ gutjnl-2012-302084]
34. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-Analysis. Lancet 2002; 359: 14-22 [PMID: 11809181 DOI: 10.1016/S0140-6736(02)07273-2]
35. Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 2006; 4: 130-142 [PMID: 16469671 DOI: 10.1016/j.cgh.2005.10.006]
36. Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. Am J Gastroenterol 2006; 101: S644-S653 [PMID: 17177870]
37. Matsuo K, Hamajima N, Suzuki T, Nakamura T, Matsuura A, Tominaga S. Better ROC Curves for a Regionally Developed Helicobacter Pylori Antibody Test. Asian Pac J Cancer Prev 2001; 2: 155-156 [PMID: 12718648]
38. Fujioka T, Tokieda M. Validity of serum anti-Helicobacter pylori antibody using enzyme immunoassay for the diagnosis in eradication of Helicobacter pylori [in Japanese]. Jpn J Med Pharm Sci 2000; 43: 573-579
39. Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mgraud F, Zerbib F, Raymond J, Fauchre JL. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter 2013; 18: 169-179 [PMID: 23316886 DOI: 10.1111/hel.12030]